THE GLOBAL RAPID DIAGNOSTICS MARKET SIZE TO REACH USD 43 BILLION BY 2025, GROWING AT A CAGR OF 10% DURING THE FORECAST PERIOD

Rapid Diagnostics Market Size, Share, Trends Analysis Report by End-users (Hospitals & Clinics, Laboratories, Individuals/Homecare Healthcare Settings, and Others), Products (Consumables and Analyzers/Instruments), Prescription (Professional Diagnostics and Home/OTC based Testing), Application (Blood Glucose Testing, Cardiometabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drug Abuse Testing, and Pregnancy & Fertility/Ovulation Testing), and Geography (APAC, North America, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

274 Pages

icon-table

61 Tables

icon-chart

128 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

45 Companies

icon-market

5 Market Segment

Rapid Diagnostics Market Report Scope

Report Attribute Details
MARKET SIZE (REVENUE) USD 43 BILLION (2025)
CAGR 10% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments End-users (Hospitals & Clinics, Laboratories, Individuals/Homecare Healthcare Settings and Others), Products (Consumables and Analyzers/Instruments), Prescription (Professional Diagnostics and Home/OTC based Testing), Application (Blood Glucose Testing, Cardiometabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drug Abuse Testing, and Pregnancy & Fertility/Ovulation Testing)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Turkey, South Africa, and Saudi Arabia

INDUSTRY INSIGHTS

The global rapid diagnostics market size to cross USD 43 billion by 2025, growing at a CAGR of 10% during 2020-2025. The global rapid diagnostics market is one of the major segments of the global in-vitro diagnostics market. The segment has experienced unprecedented growth after the outbreak of the novel coronavirus. The pandemic, which was initially identified in Wuhan, Hubei Province, China, in December 2019, infected over 35.7 million people, resulting in approximately 1.05 million deaths across the globe till the end of September 2020. In response to the growing COVID-19 pandemic and the shortage of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. These simple test kits are based either on the detection of proteins from the COVID-19 virus in respiratory samples (e.g., sputum, throat swab) or the detection in blood or serum of human antibodies generated in response to the infection. 

SNIPPETS

  • The consumables segment is expected to grow at the highest CAGR during the forecast period because of the growing usage of rapid tests in several POC sites.
  • The blood glucose testing segment is likely to reach over $26 billion by 2025 due to the high prevalence of diabetics and other comorbidities.
  • The at-home testing segment is projected to observe a revenue of close to $23 billion by 2025 because of the increased preference for home-based healthcare services convenient and cost-effective.
  • North America is expected to observe an incremental growth of over $6 billion by 2025 because of the eruption of several contagious diseases, such as COVID-19.

GLOBAL RAPID DIAGNOSTICS MARKET SEGMENTATION 

This research report includes a detailed segmentation by

  • Product
  • End-users
  • Application
  • Prescription
  • Geography

 INSIGHTS BY APPLICATION

In 2019, the blood glucose testing segment accounted for over 61% of the rapid diagnostics market. Point of care testing (POCT) for glucose levels is a common procedure performed several times a day in different medical settings worldwide. POCT glucose devices deliver rapid and relatively precise glucose measurements performed on the blood at patients’ bedsides, thereby offering quick results. New technology is constantly being introduced. Implantable sensor devices for continuous glucose monitoring that last three to seven days have been approved by the FDA and allow for strict glycemic controls with less discomfort for the patient.

The rapid cardiometabolic testing segment constituted a share of over 11% of the global market. The prevalence of chronic cardiovascular and metabolic diseases is increasing across the globe. Cardiovascular diseases (CVDs) are a major cause of death across the globe. An estimated 17.9 million deaths take place annually due to CVDs. Moreover, the prevalence of cardiovascular diseases is increasing due to lifestyle changes and an increase in diabetes, hypertension, obesity/overweight among young and elderly groups. Hence, the rise in cardiovascular and lifestyle diseases is expected to affect the market positively.  

Rapid infectious disease tests are critical for early disease detection for improving global health. Advances in diagnostics could improve clinical management of a range of diseases in the healthcare system. The ability to rapidly diagnose infectious disease has been identified as a strategic priority by several institutes, thereby increasing the infectious disease diagnostic market's growth.

 INSIGHTS BY PRODUCT

In 2019, the consumables segment accounted for a share of over 73%. The increasing share can be attributed to the high usage of a wide array of standard reagents and test kits to perform several tests. The usage of consumables is reoccurring in nature; the consumables segment generates continuous revenue for vendors. Therefore, several renowned vendors are manufacturing consumables required for analyzers. 

The instruments/analyzers segment is growing at a slower pace than the consumables segment. The purchase of instruments/analyzers requires large investments and budget allocations. However, the usage of POC instruments is increasing slowly. An increase in the prevalence of several acute and chronic diseases such as cardiovascular diseases, hepatitis, HIV, cancer, chronic kidney disease, diabetes, and sexually transmitted diseases (STDs) contributes majorly toward the growing demand for rapid test kits POC analyzers.

 INSIGHTS BY PRESCRIPTION  

The blood glucose testing segment is growing at a significant rate. The growth can be attributed to the growing demand for compact and portable benchtop analyzers, handheld analyzers, and professional rapid test kits for diagnosing various acute and chronic diseases in low-resource and ambulatory care settings. Professional healthcare settings, such as physician office labs, clinics, emergency care centers, critical care in hospitals, nursing homes, community care centers, home care centers such as geriatric and pediatric care centers are performing a broad range of POC diagnostic tests for quick diagnosis and deciding on prescribing the appropriate treatment for patients.

The trend of self-testing is slowly growing across developing countries, especially for blood glucose, pregnancy and ovulation, and blood coagulation testing. This trend is in the mature stage in developed countries.  The prevalence of chronic diseases and infectious diseases is increasing across the globe. The demand for several at-home tests increases at a steady pace as people have shifted their focus toward home-based healthcare services due to convenience and cost-effectiveness. Self-testing and screening kits continue to garner widespread attention and recognition from major key stakeholders.

 INSIGHTS BY END-USERS

In 2019, the home care segment accounted for 51% of the global rapid diagnostic testing market. Home care settings have become popular, and the demand for these settings has been growing globally. The demand is extremely high in developed countries.  Several factors, such as changes in demography and epidemiology, have affected the popularity of home settings. A rise in communicable/contagious diseases such as the COVID-19 virus has influenced the demand for home care setting and rapid diagnostics tests for COVID-19.  Several lifestyle-related diseases such as diabetes, heart and respiratory diseases, stroke, and cancer could be effectively and efficiently taken care of at home with appropriate support. Moreover, changes in social norms, values, and behavior contribute to the increasing demand for formal home care services.

The hospital's end-user segment accounted for the share of 25% in 2019 due to the high volume of infectious disease diagnosis being performed in this setting. Also, hospitals' market dominance end-user segment is due to an increase in the number of private hospitals that have their own central laboratories performing a huge volume of rapid tests.

The number of private and public laboratories is growing in major cities worldwide due to an increase in epidemic conditions and the increased prevalence of infectious diseases such as malaria, dengue, and HIV. Therefore, the demand for diagnosis testing plays an important role in preventing the spread of acute diseases and making important clinical decisions regarding treatment regimens.

 INSIGHTS BY GEOGRAPHY

North America accounted for a major share of over 38% in the global rapid diagnostics market. The growing pool of patient population with several infectious diseases such as hepatitis, TB, and HIV is expected to drive the market growth. There is an increase in the prevalence of various diseases in North America, especially STDs and COVID-19. The outbreak of Ebola and Zika viruses has been among several infectious diseases that have caught the attention of diagnostic testing developers. The COVID-19 virus has affected the US adversely and has increased rapid testing to prevent and spread in the US. The US has conducted the highest number of COVID-19 tests in the world. It conducted more than 87 million tests to prevent the spread of the disease. In March 2020, the US FDA authorized an emergency use authorization of the first point-of-care rapid test to detect the virus.

INSIGHTS BY VENDORS

The global rapid disease diagnostics market is highly dynamic, with several global and local players offering a diverse range of instruments/analyzers and reagents for diagnosing infectious and other diseases. The market is consolidated with global players accounting for dominant shares. Abbott, BD, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players that account for significant shares in the rapid diagnostics market. Global players focus on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Abbott, F. Hoffmann-La Roche, Danaher, Quidel, Luminex, and BD are continuously focusing on product development and offering new diagnostics technology to increase their market presence.

The rapid diagnostics market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

 By Application  

  • Blood Glucose Testing
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drug Abuse Testing
  • Pregnancy & Fertility/Ovulation Testing

By Products 

  • Consumables
  • Analyzers/Instruments

By End-user

  • Hospitals & Clinics
  • Laboratories
  • Individuals/Homecare
  • Others

 By Geography 

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Turkey

Frequently Asked Questions

What is the rapid diagnostics market size and growth rate during the forecast period?

The rapid diagnostics market size to reach over USD 43 billion by 2025, growing at a CAGR of close to 10% during the forecast period.

What are the factors affecting the growth of the rapid diagnostics market share?

The outbreak of the COVID-19 pandemic and the growing prevalence of several acute and chronic diseases are expected to drive the market.

What is the growth of APAC rapid diagnostics market share during the forecast period?

The APAC rapid diagnostics market is expected to observe an incremental growth of over USD 5 billion by 2025.

Who are the leading vendors in the rapid diagnostics market?

Abbott, F.Hoffman-La Roche, and Siemens Healthineers are the key players in the rapid diagnostics market.

Download Free Sample

The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019–2025. 

The following factors are likely to contribute to the growth of the rapid diagnostics market during the forecast period:

  • Increased Demand for Rapid COVID-19 Testing
  • High Demand for Rapid Molecular Diagnostic Tests
  • Growing Prevalence/Incidence of Several Acute & Chronic Diseases 

Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the rapid diagnostics market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Hoffmann-La Roche
  • Siemens Healthineers 

Other Prominent Vendors

  • Abaxis
    • Business Overview
    • Product Offerings
  • Abingdon Health
  • ACON Laboratories
  • AgaMatrix
  • Arbor Vita
  • Assure Tech
  • Autobio
  • Beijing Wantai Biopharma
  • BioMedomics
  • Biomerica
  • bioMérieux
  • Biopanda Reagents
  • Chembio Diagnostic Systems
  • Cellex
  • Clinical Reference Laboratory
  • CTK Biotech
  • EKF Diagnostics
  • Exact Sciences
  • Hangzhou AllTest Biotech
  • Hangzhou Biotest Biotech
  • Healgen Scientific
  • Instrumentation Laboratory
  • Megna Health
  • Meridian Bioscience
  • MP Biomedicals
  • NOWDiagnostics
  • Salofa Oy
  • Sekisui Diagnostics
  • SEASUN BIOMATERIALS
  • Sinocare
  • SureScreen Diagnostics
  • Sysmex
  • Swiss Precision Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Xiamen Biotime Biotechnology
  • Zhejiang Orient Gene Biotech

Upcoming Companies

  • Ascensia Diabetes Care Holdings
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • LifeScan
  • BD
  • Quidel
  • Danaher

By Application  

  • Blood Glucose Testing
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drug Abuse Testing
  • Pregnancy & Fertility/Ovulation Testing

By Products 

  • Consumables
  • Analyzers/Instruments

By End-user

  • Hospitals & Clinics
  • Laboratories
  • Individuals/Homecare
  • Others 

By Geography 

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Turkey

1              Research Methodology

2              Research Objectives

3              Research Process

 

4              Scope & Coverage

4.1          Market Definition

4.1.1      Inclusions

4.1.2      Exclusions

4.2          Base Year

4.3          Scope of The Study

4.4          Market Segments

4.4.1      Market Segmentation by Product

4.4.2      Market Segmentation by Application

4.4.3      Market Segmentation by Prescription

4.4.4      Market Segmentation by End-Users

4.4.5      Market Segmentation by Geography

 

5              Report Assumptions & Caveats

5.1          Key Caveats

5.2          Currency Conversion

5.3          Market Derivation

 

6              Market at a Glance

7              Introduction

7.1          Overview

7.1.1      Economic Benefits of Rapid Diagnostic Testing

 

8              Market Opportunities & Trends

8.1          Increase In Demand For Rapid Tests Due To Covid-19

8.2          Growing Demand For Rapid Molecular Diagnostic Tests

8.3          New Rapid Diagnostics’ Approvals/Launches

 

9              Market Growth Enablers

9.1          Increase In Prevalence/Incidence Of Several Acute And Chronic Diseases

9.2          Preference For Early Diagnosis & Disease Prevention

9.3          Focus on Innovative Rapid Diagnostic Platforms

 

10           Market Restraints

10.1        Stringent Regulations Coupled With Product Recalls

10.2        Limitations And Data Accuracy Challenges With Rapid Diagnostics

 

11           Market Landscape

11.1        Market Overview

11.2        Market Size & Forecast

11.3        Five Forces Analysis

11.3.1    Threat of New Entrants

11.3.2    Bargaining Power of Suppliers

11.3.3    Bargaining Power of Buyers

11.3.4    Threat of Substitutes

11.3.5    Competitive Rivalry

 

12           Product

12.1        Market Snapshot & Growth Engine

12.2        Market Overview

12.3        Consumables

12.3.1    Market Overview

12.3.2    Market Size & Forecast

12.4        Instruments/Analyzers

12.4.1    Market Overview

12.4.2    Market Size & Forecast

 

13           Application

13.1        Market Snapshot & Growth Engine

13.2        Market Overview

13.3        Blood Glucose Testing

13.3.1    Market Overview

13.3.2    Market Size & Forecast

13.4        Rapid Cardiometabolic Testing

13.4.1    Market Overview

13.4.2    Market Size & Forecast

13.5        Rapid Infectious Disease Testing

13.5.1    Market Overview

13.5.2    Market Size & Forecast

13.6        Rapid Blood Coagulation Testing

13.6.1    Market Overview

13.6.2    Market Size & Forecast

13.7        Rapid Hematology Testing

13.7.1    Market Overview

13.7.2    Market Size & Forecast

13.8        Rapid Cancer Testing

13.8.1    Market Overview

13.8.2    Market Size & Forecast

13.9        Rapid Drugs Of Abuse Testing

13.9.1    Market Overview

13.9.2    Market Size & Forecast

13.10     Pregnancy And Fertility/Ovulation Testing

13.10.1  Market Overview

13.10.2  Market Size & Forecast

 

14           Prescription

14.1        Market Snapshot & Growth Engine

14.2        Market Overview

14.3        Professional POC Diagnostics

14.3.1    Market Overview

14.3.2    Market Size & Forecast

14.4        AT-HOME/OTC-BASED Rapid Diagnostics

14.4.1    Market Overview

14.4.2    Market Size & Forecast

 

15           End-Users

15.1        Market Snapshot & Growth Engine

15.2        Market Overview

15.3        Hospitals And Clinics

15.3.1    Market Overview

15.3.2    Market Size & Forecast

15.4        Laboratories

15.4.1    Market Overview

15.4.2    Market Size & Forecast

15.5        Home Care

15.5.1    Market Overview

15.5.2    Market Size & Forecast

15.6        Others

15.6.1    Market Overview

15.6.2    Market Size & Forecast

 

16           Geography

16.1        Market Snapshot & Growth Engine

16.2        Geographic Overview

 

17           North America

17.1        Market Overview

17.2        Market Size & Forecast

17.3        Key Countries

17.3.1    US: Market Size & Forecast

17.3.2    Canada: Market Size & Forecast

 

18           Europe

18.1        Market Overview

18.2        Market Size & Forecast

18.3        Key Countries

18.3.1    Germany: Market Size & Forecast

18.3.2    France: Market Size & Forecast

18.3.3    UK: Market Size & Forecast

18.3.4    Italy: Market Size & Forecast

18.3.5    Spain: Market Size & Forecast

 

19           APAC

19.1        Market Overview

19.2        Market Size & Forecast

19.3        Key Countries

19.3.1    China: Market Size & Forecast

19.3.2    Japan: Market Size & Forecast

19.3.3    Australia: Market Size & Forecast

19.3.4    South Korea: Market Size & Forecast

19.3.5    India: Market Size & Forecast

 

20           Latin America

20.1        Market Overview

20.2        Market Size & Forecast

20.3        Key Countries

20.3.1    Brazil: Market Size & Forecast

20.3.2    Mexico: Market Size & Forecast

20.3.3    Argentina: Market Size & Forecast

 

21           Middle East And Africa

21.1        Market Overview

21.2        Market Size & Forecast

21.3        KEY COUNTRIES

21.3.1    Turkey: Market Size & Forecast

21.3.2    South Africa: Market Size & Forecast

21.3.3    Saudi Arabia: Market Size & Forecast

 

22           Competitive Landscape

22.1        Competition Overview

22.2        Market Share Analysis

22.2.1    Abbott

22.2.2    Siemens Healthineers

22.2.3    BD

22.2.4    Quidel

22.2.5    Danaher

22.2.6    F. Hoffmann-La Roche

22.2.7    LifeScan

22.2.8    Ascensia Diabetes Care Holdings

 

23           Key Company Profiles

23.1        Abbott

23.1.1    Business Overview

23.1.2    Product Offerings

23.1.3    Key Strategies

23.1.4    Key Strengths

23.1.5    Key Opportunities

23.2        F. Hoffmann-La Roche

23.2.1    Business Overview

23.2.2    Product Offerings

23.2.3    Key Strategies

23.2.4    Key Strengths

23.2.5    Key Opportunities

23.3        Siemens Helathineers

23.3.1    Business Overview

23.3.2    Product Offerings

23.3.3    Key Strategies

23.3.4    Key Strengths

23.3.5    Key Opportunities

 

24           Key Companies To Watch

24.1        Ascensia Diabetes Care Holdings

24.1.1    Business Overview

24.1.2    Product Offerings

24.1.3    Key Strategies

24.1.4    Key Strengths

24.1.5    Key Opportunities

24.2        LifeScan

24.2.1    Business Overview

24.2.2    Product Offerings

24.2.3    Key Strategies

24.2.4    Key Strengths

24.2.5    Key Opportunities

24.3        BD

24.3.1    Business Overview

24.3.2    Product Offerings

24.3.3    Key Strategies

24.3.4    Key Strengths

24.3.5    Key Opportunities

24.4        QUIDEL

24.4.1    Business Overview

24.4.2    Product Offerings

24.4.3    Key Strategies

24.4.4    Key Strengths

24.4.5    Key Opportunities

24.5        Danaher

24.5.1    Business Overview

24.5.2    Product Offerings

24.5.3    Key Strategies

24.5.4    Key Strengths

24.5.5    Key Opportunities

 

25           Other Prominent Vendors

25.1        Abaxis

25.1.1    Business Overview

25.1.2    Product Offerings

25.2        Abingdon Health

25.2.1    Business Overview

25.2.2    Product Offerings

25.3        ACON Laboratories

25.3.1    Business Overview

25.3.2    Product Offerings

25.4        AgaMatrix

25.4.1    Business Overview

25.4.2    Product Offerings

25.5        Arbor Vita

25.5.1    Business Overview

25.5.2    Product Offerings

25.6        Assure Tech

25.6.1    Business Overview

25.6.2    Product Offerings

25.7        Autobio

25.7.1    Business Overview

25.7.2    Product Offerings

25.8        Beijing Wantai BioPharm

25.8.1    Business Overview

25.8.2    Product Offerings

25.9        BioMedomics

25.9.1    Business Overview

25.9.2    Product Offerings

25.10     Biomerica

25.10.1  Business Overview

25.10.2  Product Offerings

25.11     bioMérieux

25.11.1  Business Overview

25.11.2  Product Offerings

25.12     Biopanda Reagents

25.12.1  Business Overview

25.12.2  Product Offerings

25.13     Chembio Diagnostic Systems

25.13.1  Business Overview

25.13.2  Product Offerings

25.14     Cellex

25.14.1  Business Overview

25.14.2  Product Offerings

25.15     Clinical Reference Laboratory

25.15.1  Business Overview

25.15.2  Product Offerings

25.16     CTK Biotech

25.16.1  Business Overview

25.16.2  Product Offerings

25.17     EKF Diagnostics

25.17.1  Business Overview

25.17.2  Product Offerings

25.18     Exact Sciences

25.18.1  Business Overview

25.19     Hangzhou AllTest Biotech

25.19.1  Business Overview

25.19.2  Product Offerings

25.20     Hangzhou Biotest Biotech

25.20.1  Business Overview

25.20.2  Product Offerings

25.21     Healgen Scientific

25.21.1  Business Overview

25.21.2  Product Offerings

25.22     Instrumentation Laboratory

25.22.1  Business Overview

25.22.2  Product Offerings

25.23     Megna Health

25.23.1  Business Overview

25.23.2  Product Offerings

25.24     Meridian Bioscience

25.24.1  Business Overview

25.24.2  Product Offerings

25.25     MP Biomedicals

25.25.1  Business Overview

25.25.2  Product Offerings

25.26     NOWDiagnostics

25.26.1  Business Overview

25.26.2  Product Offerings

25.27     Salofa Oy

25.27.1  Business Overview

25.27.2  Product Offerings

25.28     Sekisui Diagnostics

25.28.1  Business Overview

25.29     SEASUN BIOMATERIALS

25.29.1  Business Overview

25.29.2  Product Offerings

25.30     Sinocare

25.30.1  Business Overview

25.30.2  Product Offerings

25.31     SureScreen Diagnostics

25.31.1  Business Overview

25.31.2  Product Offerings

25.32     Sysmex

25.32.1  Business Overview

25.32.2  Product Offerings

25.33     Swiss Precision Diagnostics

25.33.1  Business Overview

25.33.2  Product Offerings

25.34     Thermo Fisher Scientific

25.34.1  Business Overview

25.34.2  Product Offerings

25.35     Trinity Biotech

25.35.1  Business Overview

25.35.2  Product Offerings

25.36     Xiamen Biotime BiotechnOlogy

25.36.1  Business Overview

25.36.2  Product Offerings

25.37     Zhejiang Orient Gene Biotech

25.37.1  Business Overview

25.37.2  Product Offerings

 

26           Report Summary

26.1        Key Takeaways

26.2        Strategic Recommendations

 

27           Quantitative Summary

27.1        Market By Geography

27.2        Market By Product

27.3        Product By Prescription

27.4        Market By Applications

27.5        Market By End-Users

 

28           Appendix

28.1        Abbreviations

 

List Of Exhibits 

Exhibit 1               Segmentation of Global Rapid Diagnostics Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Advantages of Rapid Diagnostic Tests

Exhibit 4               Laboratory and Rapid Tests Performed in Various Healthcare Settings

Exhibit 5               Impact of Increase in Demand for the Rapid Tests Due to COVID-19

Exhibit 6               Top Four Countries with the Highest Number of COVID-19 Cases Globally, as of 28-09-2020

Exhibit 7               Impact of Growing Demand for Rapid Molecular Diagnostic Tests

Exhibit 8               Impact of New Rapid Diagnostics’ Product Approvals/Launches

Exhibit 9               Impact of Growing Prevalence/Incidence of Several Acute & Chronic Diseases

Exhibit 10             Global Diabetes Prevalence 2017-20245 (million)

Exhibit 11             Number of People with HIV/AIDS 2019 (million)

Exhibit 12             Impact of Preference for Early Diagnosis & Disease Prevention

Exhibit 13             Advantages of Early Diagnosis & Disease Prevention

Exhibit 14             Impact of Focus on Innovative Rapid Diagnostic Platforms

Exhibit 15             Impact of Stringent Regulations Coupled with Product Recalls

Exhibit 16             Impact of Limitations and Data Accuracy Challenges with Rapid Diagnostics

Exhibit 17             Major Limitations of Rapid Diagnostic Tests

Exhibit 18             Common Errors in POC Diagnostic Tests

Exhibit 19             Global Rapid Diagnostic Market by Product

Exhibit 20             Global Rapid Diagnostic Market by Application

Exhibit 21             Global Rapid Diagnostic Market by Prescription

Exhibit 22             Global Rapid Diagnostic Market by End-User

Exhibit 23             Global Rapid Diagnostic Market by Geography

Exhibit 24             Global Rapid Diagnostics Market 2019–2025 ($ billion)

Exhibit 25             Five Forces Analysis 2019

Exhibit 26             Incremental Growth by Segment 2019 & 2025

Exhibit 27             Global Testing Market by Product

Exhibit 28             Global Rapid Testing Market by Product: Incremental Growth

Exhibit 29             Global Rapid Testing Market by Product: Absolute Growth

Exhibit 30             Global Rapid Testing Market by Consumables: Incremental Growth Versus Absolute Growth

Exhibit 31             Global Rapid Testing Market – Consumables 2019–2025 ($Billion)

Exhibit 32             Global Rapid Testing Market by Instruments/ Analyzers: Incremental Growth Versus Absolute Growth

Exhibit 33             Global Rapid Testing Instruments and Analyzers Market 2019–2025 ($ Billion)

Exhibit 34             Incremental Growth by Application 2019 & 2025

Exhibit 35             Global Rapid Diagnostics Market by Applications

Exhibit 36             Global Rapid Diagnostics Market by Applications: Incremental Growth

Exhibit 37             Global Rapid Diagnostics Market by Applications: Absolute Growth

Exhibit 38             Global Rapid Diagnostics Market by Applications - Blood Glucose Testing: Incremental Growth Versus Absolute Growth

Exhibit 39             Global Rapid Blood Glucose Testing Diagnostics Market 2019–2025 ($ billion)

Exhibit 40             Global Rapid Diagnostics Market by Applications – Cardiovascular and Metabolic Testing: Incremental Growth Versus Absolute Growth

Exhibit 41             Global Rapid Diagnostics CardioMetabolic Testing Market 2019–2025 ($ Billion)

Exhibit 42             Global Rapid Diagnostics Market by Applications – Infectious Disease: Incremental Growth Versus Absolute Growth

Exhibit 43             Global Rapid Diagnostics Infectious Disease Testing Market 2019–2025 ($ Billion)

Exhibit 44             Staff Time Spent on Testing and Prescribing VKAs (Minutes/day) Before and After POCT Use

Exhibit 45             Global Rapid Diagnostics Market by Applications –Blood Coagulation Rapid Testing: Incremental Growth Versus Absolute Growth

Exhibit 46             Global Rapid Blood Coagulation Testing Market 2019–2025 ($ Billion)

Exhibit 47             Global Rapid Diagnostics Market by Applications - Hematology Testing: Incremental Growth Versus Absolute Growth

Exhibit 48             Global Rapid Hematology Testing Market 2019–2025 ($ Billion)

Exhibit 49             Global Rapid Diagnostics Market by Applications – Rapid Cancer Testing: Incremental Growth Versus Absolute Growth

Exhibit 50             Global Rapid Cancer Testing Diagnostics Market 2019–2025 ($ billion)

Exhibit 51             Comparison of Rapid & Lab-Based Drug Screening in Urine Samples Based on Turnaround Time (Minutes)

Exhibit 52             Global Rapid Diagnostics Market by Applications – Rapid Drugs of Abuse Testing: Incremental Growth Versus Absolute Growth

Exhibit 53             Global Rapid Drug of Abuse Testing 2019–2025 ($ billion)

Exhibit 54             Global Rapid Diagnostics Market by Applications - Pregnancy & Fertility/ Ovulation Testing: Incremental Growth Versus Absolute Growth

Exhibit 55             Global Rapid Diagnostics Pregnancy & Fertility/ Ovulation Market 2019–2025 ($ Billion)

Exhibit 56             Incremental Growth by Segment 2019 & 2025

Exhibit 57             Global Rapid Testing Market by Prescription

Exhibit 58             Global Rapid Diagnostics Market by Prescription: Incremental Growth

Exhibit 59             Global Rapid Diagnostics Market by Prescription: Absolute Growth

Exhibit 60             Global Rapid Diagnostics Market by Professional POC Diagnostics: Incremental Growth Versus Absolute Growth

Exhibit 61             Global Rapid Professional Rapid Testing Market 2019–2025 ($ Billion)

Exhibit 62             Global Rapid Diagnostics Market by Home/OTC-Based Rapid Diagnostics: Incremental Growth Versus Absolute Growth

Exhibit 63             Global Rapid Home/OTC-Based Rapid Diagnostics Market 2019–2025 ($ Billion)

Exhibit 64             Incremental Growth by End-User 2019 & 2025

Exhibit 65             Global Rapid Diagnostics Market by End-User

Exhibit 66             Global Rapid Testing Market by End-Users: Incremental Growth

Exhibit 67             Global Rapid Testing Market by End-Users: Absolute Growth

Exhibit 68             Comparison of Time Used in the Emergency Departments (minutes)

Exhibit 69             Global Rapid Testing Market by End-Users – Hospitals and Clinics: Incremental Growth Versus Absolute Growth

Exhibit 70             Global Rapid Testing Hospitals & Clinics Market 2019–2025 ($ Billion)

Exhibit 71             Global Rapid Testing Market by End-users – Laboratories: Incremental Growth Versus Absolute Growth

Exhibit 72             Global Rapid Testing Laboratories Market 2019–2025 ($ Billion)

Exhibit 73             Global Rapid Testing Market by End-Users – Home Care: Incremental Growth Versus Absolute Growth

Exhibit 74             Global Rapid Testing Home Care Market 2019–2025 ($ Billion)

Exhibit 75             Global Rapid Testing Market by End-Users – Others: Incremental Growth Versus Absolute Growth

Exhibit 76             Global Rapid Testing Others Market 2019–2025 ($ Billion)

Exhibit 77             Incremental Growth by Geography 2019 & 2025

Exhibit 78             Global Rapid Diagnostics Market by Geography

Exhibit 79             Global Rapid Testing Market by Geography: Incremental Growth

Exhibit 80             Global Rapid Testing Market by Geography: Absolute Growth

Exhibit 81             Global Rapid Testing Market in North America: Incremental Growth Versus Absolute Growth

Exhibit 82             Rapid Diagnostics Market – North America

Exhibit 83             Rapid Testing Market in North America 2019–2025 ($ Billion)

Exhibit 84             Incremental Growth in North America 2019 & 2025

Exhibit 85             Rapid Diagnostics Market in US 2019–2025 ($ Billion)

Exhibit 86             Rapid Diagnostics Market in Canada 2019–2025 ($ Billion)

Exhibit 87             Rapid Diagnostics Market in Europe: Incremental Growth Versus Absolute Growth

Exhibit 88             Rapid Diagnostics Market in Europe 2019–2025 ($ Billion)

Exhibit 89             Incremental Growth in Europe 2019 & 2025

Exhibit 90             Rapid Diagnostics Market in Germany 2019–2025 ($ Billion)

Exhibit 91             Rapid Diagnostics Market in France 2019–2025 ($ Billion)

Exhibit 92             Rapid Diagnostics Market in UK 2019–2025 ($ Billion)

Exhibit 93             Rapid Diagnostics Market in Italy 2019–2025 ($ Billion)

Exhibit 94             Rapid Diagnostics Market in Spain 2019–2025 ($ Billion)

Exhibit 95             Global Rapid Testing Market APAC: Incremental Growth Versus Absolute Growth

Exhibit 96             Rapid Diagnostics Market in APAC 2019–2025 ($ Billion)

Exhibit 97             Incremental Growth in APAC 2019 & 2025

Exhibit 98             Rapid Diagnostics Market in China 2019–2025 ($ Billion)

Exhibit 99             Rapid Diagnostics Market in Japan 2019–2025 ($ billion)

Exhibit 100          Rapid Diagnostics Market in Australia 2019–2025 ($ billion)

Exhibit 101          Rapid Diagnostics Market in South Korea 2019–2025 ($ Billion)

Exhibit 102          Rapid Diagnostics Market in India 2019–2025 ($ Billion)

Exhibit 103          Rapid Diagnostics Market in Latin America 2019 (Billion)

Exhibit 104          Rapid Diagnostics Market in Latin America: Incremental Growth Versus Absolute Growth

Exhibit 105          Rapid Diagnostics Market in Latin America 2019–2025 ($ Billion)

Exhibit 106          Incremental Growth in Latin America 2019 & 2025

Exhibit 107          Rapid Diagnostics Market in Brazil 2019–2025 ($ Billion)

Exhibit 108          Rapid Diagnostics Market in Mexico 2019–2025 ($ Billion)

Exhibit 109          Rapid Diagnostics Market in Argentina 2019–2025 ($ Billion)

Exhibit 110          Global Rapid Testing Market Middle East and Africa: Incremental Growth Versus Absolute Growth

Exhibit 111          Rapid Diagnostics in the Middle East and Africa – (Billion)

Exhibit 112          Rapid Diagnostics Market in Middle East & Africa 2019–2025 ($ billion)

Exhibit 113          Incremental Growth in Middle East and Africa 2019 & 2025

Exhibit 114          Rapid Diagnostics Market in Turkey 2019–2025 ($ Billion)

Exhibit 115          Rapid Diagnostics Market in South Africa 2019–2025 ($billion)

Exhibit 116          Rapid Diagnostics Market in Saudi Arabia 2019–2025 ($ billion)

Exhibit 117          Abbott: Sales Breakdown by Segments in 2018−2019 ($ million)

Exhibit 118          Abbott: Net Sales 2017−2019 ($ million)

Exhibit 119          Abbott: Net Sales breakdown by Diagnostics Product Segment 2018−2019 ($ million)

Exhibit 120          F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)

Exhibit 121          F. Hoffmann-La Roche: Revenue by Geographies 2019 (%)

Exhibit 122          Quidel: Revenue 2017−2019 ($ million)

Exhibit 123          Quidel: Research and Development Expenses 2017−2019 ($ million)

Exhibit 124          Danaher: Revenue by Segment 2018 & 2019 ($ million)

Exhibit 125          Danaher: Net Sales 2017−2019 ($ million)

Exhibit 126          Danaher: Revenue by Geography 2019

Exhibit 127          Danaher: R&D Expenditure 2017−2019 ($ million)

Exhibit 128          Danaher: Diagnostics Segment Sales 2017−2019 ($ million)

               

List of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  Recent Product Launches in the Rapid Diagnostics Market

Table 4                  Popular Innovative Rapid Diagnostic Analyzers

Table 5                  Product Recalls in Rapid Diagnostics Market

Table 6                  Importance of Drug Detection

Table 7                  Abbott: Major Product Offerings

Table 8                  F. Hoffmann-La Roche: Major Product Offerings

Table 9                  Siemens Healthineers: Major Product Offerings

Table 10               Ascensia Diabetes Care Holdings: Major Product Offerings

Table 11               LifeScan: Major Product Offerings

Table 12               BD: Major Product Offerings

Table 13               Quidel: Major Product Offerings

Table 14               Danaher: Major Product Offerings

Table 15               Abaxis: Major Product Offerings

Table 16               Abingdon Health: Major Product Offerings

Table 17               ACON Laboratories: Major Product Offerings

Table 18               AgaMatrix: Major Product Offerings

Table 19               Arbor Vita: Major Product Offerings

Table 20               Assure Tech: Major Product Offerings

Table 21               Autobio: Major Product Offerings

Table 22               Beijing Wantai Biopharma: Major Product Offerings

Table 23               BioMedomics: Major Product Offerings

Table 24               Biomerica: Major Product Offerings

Table 25               bioMérieux: Major Product Offerings

Table 26               Biopanda Reagents: Major Product Offerings

Table 27               Chembio Diagnostic Systems: Major Product Offerings

Table 28               Cellex: Major Product Offerings

Table 29               Clinical Reference Laboratory: Major Product Offerings

Table 30               CTK Biotech: Major Product Offerings

Table 31               EKF Diagnostics: Major Product Offerings

Table 32               Exact Sciences: Major Product Offerings

Table 33               Hangzhou AllTest Biotech: Major Product Offerings

Table 34               Hangzhou Biotest Biotech: Major Product Offerings

Table 35               Healgen Scientific: Major Product Offerings

Table 36               Instrumentation Laboratory: Major Product Offerings

Table 37               Megna Health: Major Product Offerings

Table 38               Meridian Bioscience: Major Product Offerings

Table 39               MP Biomedicals: Major Product Offerings

Table 40               NOWDiagnostics: Major Product Offerings

Table 41               Salofa Oy: Major Product Offerings

Table 42               Sekisui Diagnostics: Major Product Offerings

Table 43               SEASUN BIOMATERIALS: Major Product Offerings

Table 44               Sinocare: Major Product Offerings

Table 45               SunScreen Diagnostics: Major Product Offerings

Table 46               Sysmex: Major Product Offerings

Table 47               Swiss Precision Diagnostics: Major Product Offerings

Table 48               Thermo Fisher Scientific: Major Product Offerings

Table 49               Trinity Biotech: Major Product Offerings

Table 50               Xiamen Biotime Biotechnology: Major Product Offerings

Table 51               Zhejiang Orient Gene Biotech: Major Product Offerings

Table 52               Global Rapid Diagnostics Market by Geography 2019−2025 ($ Billion)

Table 53               Global Rapid Diagnostics Market by Geography 2019−2025 (%)

Table 54               Global Rapid Diagnostics Market by Product 2019−2025 (& billion)

Table 55               Global Rapid Diagnostics Market by Product 2019−2025 (%)

Table 56               Global Rapid Diagnostics Market by Prescription 2019−2025 ($ billion)

Table 57               Global Rapid Diagnostics Market by Prescription 2019−2025 (%)

Table 58               Global Rapid Diagnostics Market by Application 2019−2025 ($ billion)

Table 59               Global Rapid Testing Market by Applications 2019−2025 ($ billion)

Table 60               Global Rapid Diagnostics Market by End-Users 2019−2025 ($ billion)

Table 61               Global Rapid Diagnostics Market by End-Users 2019−2025 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date